Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl-cysteine in CC-Resistant PCOS After Ovarian Drilling
NCT02775734Phase 3Completed
- Sponsor
- Ain Shams University
- Start
- May 2016
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Ain Shams University. Primary endpoint: Biochemical pregnancy rate at 6 months. Started May 2016; status: completed.
02
Drugs
acetylcysteine
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT02775734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775734.